InvestorsHub Logo
Followers 27
Posts 413
Boards Moderated 0
Alias Born 05/28/2018

Re: HDGabor post# 179613

Wednesday, 03/06/2019 1:03:49 PM

Wednesday, March 06, 2019 1:03:49 PM

Post# of 430562
HDG, Absolutely! <chuckling> I had thought about putting a note in for an assumption relating to churn (compliance) rate of like 55% or whatever, but decided to go for clarity in a sense of physical scale as I said at the end. (prior to encapsulation)

Maybe it will have a better compliance rate than statins (b/c "natural source", etc) or worse because it's an add-on?! At any rate, it makes modelling fuzzier.

--------------
Duke - just to clarify for understanding, crude refers to what's rendered from the source material. Then you'd have intermediates from the crude. So-

source material (fish, algae, other) > crude > intermediate > refined

IPE/V - whatever you want to call AMR101 - would be refined and purified to a pharmaceutical standard (not crude, not intermediate).

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News